Biochemistry, Genetics and Molecular Biology
Senescence
96%
Phospholipase A2
69%
Phenotype
55%
Stress
48%
Cell Death
48%
Calcium Transport
41%
Inositol 1,4,5 Trisphosphate Receptor
41%
Lysyl Oxidase
41%
Glucose Transporter
41%
Janus Kinase
41%
Estrogen-Related Receptor
41%
Aldo-Keto Reductase
41%
Potassium Channel
41%
Cancer Cell
41%
Proton Radiation
41%
X Ray
41%
DUX4
41%
Aging
41%
Cyclin-Dependent Kinase
41%
Synthase
34%
Ribosomal Protein
29%
Progeria
27%
Poly ADP Ribose Polymerase
27%
ABCC3
26%
Cyclin-Dependent Kinase
23%
AKR1C1
20%
Protein Kinase A
20%
Species
20%
Fibroblast
20%
Aptitude
19%
Cell Aging
19%
Cell Transformation
16%
Stable Cell
16%
Ectopic Expression
13%
Uniporter
13%
Membrane Potential
13%
Progerin
13%
Cell Fate
13%
Bcl-2 Family
13%
Comprehension
13%
Messenger RNA
13%
Cytotoxicity
13%
Proton
13%
Photon
13%
Radiosensitivity
13%
Galactosidase
13%
P53
13%
P21
13%
Morphology
13%
Cyclin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Pancreas Adenocarcinoma
41%
Anticarcinogen
41%
Temozolomide
41%
Drug Distribution
41%
Phenanthridine Derivative
41%
Amaryllidaceae Alkaloid
41%
Lycorine
41%
Protein Lysine 6 Oxidase
41%
Oligodendroglioma
41%
Pyrroloiminoquinone Derivative
41%
Ciprofloxacin
41%
Cyclin Dependent Kinase
41%
Antitumor Activity
41%
Carbon
41%
Proton
41%
Pancreas Cancer
41%
Ribosome Protein
34%
Alkaloid
20%
Neoplasm
15%
Gemcitabine
13%
Cycline
13%
Navitoclax
13%
Cell Cycle
13%
Melanoma
10%
Solid Malignant Neoplasm
9%
Fibrillar Collagen
9%
Survival
8%
Tumor Microenvironment
8%
Tumor Suppressor Protein
6%
Cyclin Dependent Kinase Inhibitor
6%
Protein
6%
Protein Kinase
6%
Ribosome RNA
6%
Phosphotransferase
6%
Non Small Cell Lung Cancer
5%
Cytostatic Agent
5%
Lead
5%
Metastasis
5%
Glioblastoma
5%
Mouse
5%
Medicine and Dentistry
Radiation Therapy
58%
Olaparib
41%
Pancreas Cancer
41%
Senescence
41%
X-Ray Irradiation
41%
Proton
41%
Proton Irradiation
41%
Carbon
41%
Combination Therapy
29%
Cells
20%
Programmed Cell Death
20%
Patient
18%
Malignant Neoplasm
18%
Adverse Event
10%
PARP Inhibitor
10%
P21
10%
Cytotoxicity
10%
Messenger RNA
10%
Cell Fate
10%
Family
10%
Radiosensitivity
10%
Photon Therapy
10%
Cancer Treatment
10%
Proton Therapy
10%
Poly ADP Ribose Polymerase
10%
Morphology
10%
Drug
10%
Chemotherapeutic Agent
10%
Comprehension
10%
Phenotype
10%
Cell Line
10%
Galactosidase
10%
Clinical Trial
8%
Cancer Types
8%
Survival
8%
Cancer Therapy
8%
Aptitude
8%
Tumor Microenvironment
8%
Neoplasm
8%
Therapeutic Procedure
8%
